ARTG 374340Free Walk Exoskeleton - Therapy Model - Ambulation exoskeleton, clinical
ARTG ID: 374340 · Darren Pereira · FREE Bionics Taiwan Inc · Class IIa · Started September 07, 2021
Good Name: Darren Pereira - Free Walk Exoskeleton - Therapy Model - Ambulation exoskeleton, clinical
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 374340
- Start Date
- September 07, 2021
- Effective Date
- September 07, 2021
- Name
- Darren Pereira
- Country
- Taiwan
- Address
- 5F-2 No 89 Dongmei Road East District, Hsinchu City, 30070
The Free Walk Exoskeleton (Therapy Model) is battery powered bionic lower limb orthosis system designed to assist wearers with a walking disability regain lost motor function by manipulating the legs through a normal walking pattern during ambulation. The system includes a wearable exoskeleton structure that is used to train individuals in standing, rising from sitting to standing, walking and traversing various terrain. The control of the device is achieved through a user-operated wireless communicator built into a pair of forearm crutches, tilt sensor and specific body movements. It is intended for multiple- patient use in a controlled clinical setting such as a facility specialising in rehabilitation, under healthcare professional supervision.
Access comprehensive regulatory information for Free Walk Exoskeleton - Therapy Model - Ambulation exoskeleton, clinical in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 374340 and sponsored by Darren Pereira, manufactured by FREE Bionics Taiwan Inc in Taiwan. The device registration started on September 07, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.